Characterizing motor–cognitive associations in Parkinson’s disease using digital assessments

Traditional motor and cognitive assessments for people with Parkinson's disease (PD) have long faced challenges related to accessibility, scalability, and geographical diversity when administered in-person. Remote cognitive testing offers the promise of improved accessibility, reduced participant burden, and greater scalability, particularly for individuals with mobility limitations or limited access to specialized care. While remote cognitive assessments are increasingly used in PD research and clinical settings, it remains unclear whether these measures provide an informative index of PD severity. These gaps limit the interpretability and broader adoption of remote cognitive measures as accessible and scalable indicators of PD severity. To establish a benchmark, we first analyzed a large in-person dataset (PPMI; <i>n</i> = 1,417). We found significant, negative, and small correlations between a cognitive measure (MoCA) scores and two motor measures (MDS-UPDRS III, <i>ρ</i> = -0.17; and H&Y scores, <i>ρ</i> = -0.12). Second, we administered remote assessments to 152 individuals with PD across 60+ geographical locations, including a videoconference-based MoCA (MoCA-VC) and online versions of the MDS-UPDRS III and H&Y. Consistent with in-person findings, we found significant, negative, and small correlations between the MoCA-VC scores and the two motor measures (MDS-UPDRS III, <i>ρ</i> = -0.32; and H&Y scores, <i>ρ</i> = -0.16). Additionally, we examined the decrease in the MoCA score as a function of disease stage. A multivariable regression model demonstrated that each one disease stage increase in H&Y was associated with a 0.65-point decrease in MoCA (in-person settings) and a 1.16-point decrease in MoCA-VC (online settings). Together, these findings demonstrate that a remote, home-based cognitive assessment captures motor-cognitive associations comparable to those observed in large in-person settings, supporting its potential utility as an accessible and scalable cognitive index of PD severity.

Authors

Institutions

Publication Details

Journal
Frontiers in Aging Neuroscience
Published
2026-02-23
DOI
https://doi.org/10.3389/fnagi.2026.1787521
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterizing motor–cognitive associations in Parkinson’s disease using digital assessments

Avigail Lithwick Algon, William Saban
Frontiers in Aging Neuroscience
Parkinson's Disease Mechanisms and Treatments
article

Characterizing motor–cognitive associations in Parkinson’s disease using digital assessments

Avigail Lithwick Algon, William Saban
article en

Abstract

Traditional motor and cognitive assessments for people with Parkinson's disease (PD) have long faced challenges related to accessibility, scalability, and geographical diversity when administered in-person. Remote cognitive testing offers the promise of improved accessibility, reduced participant burden, and greater scalability, particularly for individuals with mobility limitations or limited access to specialized care. While remote cognitive assessments are increasingly used in PD research and clinical settings, it remains unclear whether these measures provide an informative index of PD severity. These gaps limit the interpretability and broader adoption of remote cognitive measures as accessible and scalable indicators of PD severity. To establish a benchmark, we first analyzed a large in-person dataset (PPMI; <i>n</i> = 1,417). We found significant, negative, and small correlations between a cognitive measure (MoCA) scores and two motor measures (MDS-UPDRS III, <i>ρ</i> = -0.17; and H&Y scores, <i>ρ</i> = -0.12). Second, we administered remote assessments to 152 individuals with PD across 60+ geographical locations, including a videoconference-based MoCA (MoCA-VC) and online versions of the MDS-UPDRS III and H&Y. Consistent with in-person findings, we found significant, negative, and small correlations between the MoCA-VC scores and the two motor measures (MDS-UPDRS III, <i>ρ</i> = -0.32; and H&Y scores, <i>ρ</i> = -0.16). Additionally, we examined the decrease in the MoCA score as a function of disease stage. A multivariable regression model demonstrated that each one disease stage increase in H&Y was associated with a 0.65-point decrease in MoCA (in-person settings) and a 1.16-point decrease in MoCA-VC (online settings). Together, these findings demonstrate that a remote, home-based cognitive assessment captures motor-cognitive associations comparable to those observed in large in-person settings, supporting its potential utility as an accessible and scalable cognitive index of PD severity.

Frontiers in Aging NeuroscienceVol. 18
Tel Aviv University (IL), Medical University of Graz (AT), Center for Accessible Technology (US)
Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Sanofi, Biogen, Teva Pharmaceutical Industries, Celgene, Jazz Pharmaceuticals, Neurocrine Biosciences, Verily Life Sciences, Servier, H. Lundbeck A/S, Sun Pharma, Genentech, Allergan, Avid Radiopharmaceuticals
Openalex Percentile: Top 50%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.